Search Results - "KROHN, K. A"

Refine Results
  1. 1

    [18F]FMISO and [18F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression by RAJENDRAN, J. G, WILSON, D. C, KROHN, K. A, CONRAD, E. U, PETERSON, L. M, BRUCKNER, J. D, RASEY, J. S, CHIN, L. K, HOFSTRAND, P. D, GRIERSON, J. R, EARY, J. F

    “…Hypoxia imparts resistance to radiotherapy and chemotherapy and also promotes a variety of changes in tumor biology through inducible promoters. The purpose of…”
    Get full text
    Journal Article
  2. 2

    Kinetic Quantitation of Cerebral PET-FDG Studies Without Concurrent Blood Sampling: Statistical Recovery of the Arterial Input Function by O'Sullivan, F., Kirrane, J., Muzi, M., O'Sullivan, J.N., Spence, A.M., Mankoff, D.A., Krohn, K.A.

    Published in IEEE transactions on medical imaging (01-03-2010)
    “…Kinetic quantitation of dynamic positron emission tomography (PET) studies via compartmental modeling usually requires the time-course of the radio-tracer…”
    Get full text
    Journal Article
  3. 3

    Hypoxia imaging-directed radiation treatment planning by Rajendran, J G, Hendrickson, K R G, Spence, A M, Muzi, M, Krohn, K A, Mankoff, D A

    “…Increasing evidence supports the role of the tumor microenvironment in modulating cancer behavior. Tissue hypoxia, an important and common condition affecting…”
    Get full text
    Journal Article
  4. 4

    Carbon-11-Thymidine and FDG to Measure Therapy Response by Shields, Anthony F, Mankoff, David A, Link, Jeanne M, Graham, Michael M, Eary, Janet F, Kozawa, Susie M, Zheng, Minna, Lewellen, Barbara, Lewellen, Thomas K, Grierson, John R, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-10-1998)
    “…This study was performed to determine if PET imaging with 11C-thymidine could measure tumor response to chemotherapy early after the initiation of treatment…”
    Get full text
    Journal Article
  5. 5

    Applications of PET imaging with the proliferation marker [18F]-FLT by Peck, M, Pollack, H A, Friesen, A, Muzi, M, Shoner, S C, Shankland, E G, Fink, J R, Armstrong, J O, Link, J M, Krohn, K A

    “…[18F]-3'-fluoro-3'-deoxythymidine (FLT) is a nucleoside-analog imaging agent for quantifying cellular proliferation that was first reported in 1998. It…”
    Get full text
    Journal Article
  6. 6

    [18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies by Mankoff, David A, Peterson, Lanell M, Tewson, Timothy J, Link, Jeanne M, Gralow, Julie R, Graham, Michael M, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-04-2001)
    “…[18F]16alpha-fluoroestradiol (FES) is a PET imaging agent useful for the study of estrogen receptors in breast cancer. We estimated the radiation dosimetry for…”
    Get full text
    Journal Article
  7. 7

    2-[C-11]thymidine imaging of malignant brain tumors by EARY, J. F, MANKOFF, D. A, SPENCE, A. M, BERGER, M. S, OLSHEN, A, LINK, J. M, O'SULLIVAN, F, KROHN, K. A

    Published in Cancer research (Chicago, Ill.) (01-02-1999)
    “…Malignant brain tumors pose diagnostic and therapeutic problems. Despite the advent of new brain imaging modalities, including magnetic resonance imaging (MRI)…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole by Koh, W J, Rasey, J S, Evans, M L, Grierson, J R, Lewellen, T K, Graham, M M, Krohn, K A, Griffin, T W

    “…Fluoromisonidazole (FMISO) has been shown to bind selectively to hypoxic cells in vitro and in vivo at radiobiologically significant oxygen levels. When…”
    Get more information
    Journal Article
  10. 10

    Kinetic Analysis of 2-[Carbon-11]Thymidine PET Imaging Studies: Compartmental Model and Mathematical Analysis by Mankoff, David A, Shields, Anthony F, Graham, Michael M, Link, Jeanne M, Eary, Janet F, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-06-1998)
    “…Carbon-11-thymidine is a PET tracer of DNA synthesis and cellular proliferation. Quantitative analysis of [11C]thymidine images is complicated by the presence…”
    Get full text
    Journal Article
  11. 11

    Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG : Analysis of the FDG lumped constant by SPENCE, A. M, MUZI, M, OJEMANN, G. A, GRAHAM, M. M, O'SULLIVAN, F, KROHN, K. A, LINK, J. M, LEWELLEN, T. K, LEWELLEN, B, FREEMAN, S. D, BERGER, M. S

    Published in The Journal of nuclear medicine (1978) (01-03-1998)
    “…Calculation of the glucose metabolic rate (MRGlc) in brain with PET and 2-[18F]fluoro-2-deoxy-D-glucose (FDG) requires knowing the rate of uptake of FDG…”
    Get full text
    Journal Article
  12. 12

    Kinetic Analysis of 2-[11C]Thymidine PET Imaging Studies: Validation Studies by Mankoff, David A, Shields, Anthony F, Link, Jeanne M, Graham, Michael M, Muzi, Mark, Peterson, Lanell M, Eary, Janet F, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-04-1999)
    “…2-[11C]thymidine has been tested as a PET tracer of cellular proliferation. We have previously described a model of thymidine and labeled metabolite kinetics…”
    Get full text
    Journal Article
  13. 13

    Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody by Press, O W, Eary, J F, Badger, C C, Martin, P J, Appelbaum, F R, Levy, R, Miller, R, Brown, S, Nelp, W B, Krohn, K A

    Published in Journal of clinical oncology (01-08-1989)
    “…The biodistribution, toxicity, and therapeutic potential of anti-CD37 monoclonal antibody (MoAb) MB-1 labeled with iodine 131 (131I) was evaluated in ten…”
    Get more information
    Journal Article
  14. 14

    The physical chemistry of ligand-receptor binding identifies some limitations to the analysis of receptor images by Krohn, Kenneth A

    Published in Nuclear medicine and biology (01-07-2001)
    “…The biophysical chemistry of ligand-receptor interactions imposes some restrictions on the characteristics of a radioligand if it is to be a useful tracer for…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Molecular imaging of regional brain tumor biology by Spence, A.M., Muzi, M., Krohn, K.A.

    Published in Journal of cellular biochemistry (2002)
    “…Energy metabolism measurements in gliomas in vivo are now performed widely with positron emission tomography (PET). This capability has developed from a large…”
    Get full text
    Journal Article
  16. 16

    PET radiopharmaceuticals: state-of-the-art and future prospects by Tewson, Timothy J., Krohn, Kenneth A.

    Published in Seminars in nuclear medicine (01-07-1998)
    “…In this review we provide a conceptual overview of radiopharmaceuticals containing positron-emitting isotopes, not a catalog of radiopharmaceuticals or details…”
    Get full text
    Journal Article
  17. 17

    Fluorine-18-Fluoromisonidazole Radiation Dosimetry in Imaging Studies by Graham, Michael M, Peterson, Lanell M, Link, Jeanne M, Evans, Margaret L, Rasey, Janet s, Koh, Wui-Jin, Caldwell, James H, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-10-1997)
    “…Fluoromisonidazole (FMISO), labeled with the positron emitter 18F, is a useful hypoxia imaging agent for PET studies, with potential applications in patients…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Analysis of 2-Carbon-11-Thymidine Blood Metabolites in PET Imaging by Shields, Anthony F, Graham, Michael M, Zheng, Minna, Kozawa, Susan M, Link, Jeanne M, Krohn, Kenneth A

    Published in The Journal of nuclear medicine (1978) (01-02-1996)
    “…Carbon-11-thymidine labeled in the ring-2 position was used with PET to image tumor and tissue proliferation. Since thymidine is rapidly degraded in the body,…”
    Get full text
    Journal Article
  20. 20